Agenus Inc., a medical-phase biotechnology organization, discovers and develops therapies to activate the body's immune program versus most cancers and infections in the United States and internationally. It provides Retrocyte Exhibit, an antibody expression platform for that identification of entirely human and humanized monoclonal antibodies; and